Medico Remedies is expanding capacity with a new plant to produce 25M tablets, 45M capsules, 10M dry syrups, and 10M injectables annually, focusing on antibiotic formulations for export markets.

The Rs 30 Cr investment, funded via internal accruals and debt, will be executed over two years and is expected to add around Rs 25 Cr in revenue after approvals.

This facility will enhance overall capacity from the current 70% utilization at the existing plant.